Detalles de la búsqueda
1.
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.
Liver Int
; 37(5): 678-683, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27865034
2.
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers.
Transpl Int
; 26(3): 281-9, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23230956
3.
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients.
Transpl Int
; 25(4): 448-54, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22353419
4.
Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy?
J Surg Oncol
; 105(1): 111-2, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21792942
5.
The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?
Hepat Mon
; 16(11): e41933, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28070200
6.
Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort.
Dig Liver Dis
; 47(8): 689-94, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26055490
7.
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.
Dig Liver Dis
; 46(5): 440-5, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24635906
8.
Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.
Liver Transpl
; 8(1): 10-20, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11799480
Resultados
1 -
8
de 8
1
Próxima >
>>